Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Efficacy and Safety of Tofacitinib in Patients With Polymyalgia Rheumatica

NCT04799262 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04799262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04799262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Efficacy and Safety of Tofacitinib in Patients With Polymyalgia Rheumatica
Lead sponsor
RenJi Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2021
Completion date
May 1, 2022
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug, polymyalgia rheumatica, safety issues